Lexicon Pharmaceuticals
LXRX
LXRX
126 hedge funds and large institutions have $220M invested in Lexicon Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 45 increasing their positions, 24 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
29% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 34
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
51% less capital invested
Capital invested by funds: $453M → $220M (-$233M)
Holders
126
Holding in Top 10
1
Calls
$547K
Puts
$163K
Top Buyers
| 1 | +$5.73M | |
| 2 | +$4.19M | |
| 3 | +$3.18M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.55M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.32M |
Top Sellers
| 1 | -$17.3M | |
| 2 | -$3.65M | |
| 3 | -$2.2M | |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
-$1.26M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$901K |